This text is a result of machine translation.
Shuidi company has established a new pharmaceutical innovation division to further develop the pharmaceutical direction
Gaode started the "cooling action" by taking a taxi and gave high-temperature subsidies to encourage drivers to turn on more air conditioners
Germany started the "cooling action" by taking a taxi and gave high-temperature subsidies to encourage drivers to turn on more air conditioners
Biotech Firm ImmuneOnco Submitted Listing Application on the Main Board of HKEX
ImmuneOnco, focusing on developing new-generation tumor immunotherapeutic, will further accelerate the development of other promising drug candidates targeting checkpoints of innate and adaptive immunity.
Updated 32 mins ago
CTTQ, Ampsourcebio Ink Agreement on Cure for NASH, T2DM
There are more than 95 plus major players and more than 90 plus nonalcoholic steatohepatitis (NASH) pipeline therapies, but none of them has been approved for marketing. Who would survive the competition in the blue-ocean market for NASH?
Apr 27, 2022 09:45 PM
China biopharmaceutical: the fifth indication of anti-tumor drug "arotinib hydrochloride capsule" has been approved
Jin Litai: the prices of various types of cathodic electrophoretic paint products rise by 10% - 20%